Skip to content

Effects of Photobiomodulation in Hemophilia Patients.

Effects of Photobiomodulation on Knee Hemarthosis in Patients With Hemophilia.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07579585
Enrollment
24
Registered
2026-05-12
Start date
2026-04-05
Completion date
2026-07-10
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemarthrosis, Knee, Hemophilia

Keywords

Photobiomodulation, Hemarthrosis, Hemophilia

Brief summary

Hemophilia is a genetic bleeding disorder that commonly leads to knee hemarthrosis, causing pain, swelling, and reduced joint mobility in children. While standard treatments include clotting factor replacement and physiotherapy, additional non-invasive approaches are being explored. This study aims to evaluate the effects of photobiomodulation on knee hemarthrosis in male hemophilia patients aged 9-14 years. It focuses on determining whether this therapy can reduce pain and swelling and improve joint range of motion when used alongside

Detailed description

Hemophilia is a hereditary bleeding disorder characterized by a deficiency in clottingfactors VIII or IX, leading to spontaneous or trauma-induced internal bleeding, especially into muscles and joints. Knee hemarthrosis is among the most commonanddebilitating complications in pediatric hemophilia patients, contributing to chronicjoint pain, restricted mobility, and long-term deformities. Conventional management includes clotting factor replacement and physiotherapeutic interventions such as theRICE protocol. However, complementary, non-invasive strategies are increasinglybeing explored to enhance joint health and reduce recurrent bleeding episodes. Photobiomodulation (PBM), also known as low-level laser therapy (LLLT), has shown promising effects on reducing inflammation, promoting tissue repair, andmanaging musculoskeletal pain, but its role in managing hemarthrosis in hemophiliaremains underexplored. This quasi-experimental study aims to evaluate the effects of photobiomodulationonknee hemarthrosis in male hemophilia patients aged 9 to 14 years. The study will beconducted at Sundas Foundation, Sialkot, following ethical approval fromBASAR. Atotal sample size of 24 will be selected using non-probability convenient sampling.Patients will be receiving LLLT in addition to standard care for 10 minutes for 3 days a week after an acute internal bleed or swelling. The primary outcomes assessedwill include pain intensity (using the Visual Analogue Scale), swelling (using a measuringtape), and range of motion (measured with a goniometer). Data will be collectedpre- and post-intervention to observe the effectiveness of PBM in improving joint functionand reducing hemarthrosis severity. The data will be collected using SPSS version26.

Interventions

RADIATIONphotobiomodulation

Photobiomodulation is a non-invasive therapy that uses low-level light (typically from lasers or LEDs) to stimulate cellular activity and promote healing. It works by enhancing mitochondrial function, increasing energy (ATP) production, and reducing inflammation. This therapy is commonly used for pain relief, tissue repair, and improving recovery in various clinical conditions.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
9 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* Hemophilia patients with knee hemarthosis * Patients of age 9-14 yrs will be taken * Bothmaleand female population will be included

Exclusion criteria

* Presence of open wounds at or near the treatment site. * Kneejoint subluxation. * Presence of congenital or acquired skeletal deformities. * Children diagnosed with cardiopulmonary dysfunctions. * Children with neurological deficits

Design outcomes

Primary

MeasureTime frameDescription
VAS3rd DayThe Visual Analogue Scale (VAS) is a simple and widely used tool to measure a person's pain intensity. It typically consists of a 10 cm straight line, where: One end represents "no pain" (0) The other end represents "worst possible pain" (10) The patient is asked to mark a point on the line that best represents their level of pain. The distance from the "no pain" end to the marked point is then measured and recorded as the pain score. VAS is easy to use, quick, and effective for tracking changes in pain over time in both clinical and research settings.
Measuring Tape3rd DayA measuring tape in physiotherapy is a simple, flexible tool used to assess body dimensions such as limb length, girth, and joint swelling. It helps therapists monitor changes over time, evaluate muscle atrophy or edema, and track patient progress during rehabilitation.
Goniometer3rd DayA goniometer is a scientific instrument used to measure angles. It is commonly used in fields like geometry, engineering, and healthcare. In medicine-especially in physical therapy and orthopedics-it helps measure the range of motion of joints in the human body. A typical goniometer consists of a protractor-like scale with two arms that can be aligned along the body part or object to determine the angle accurately.

Countries

Pakistan

Contacts

CONTACTImran Amjad, PhD
imran.amjad@riphah.edu.pk03324390125
CONTACTMuhammad Asif Javed, PhD*
a.javed@riphah.edu.pk+923224209422
PRINCIPAL_INVESTIGATORZaira Zeeshan, MS

Riphah International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026